Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
companyunderground
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» glioblastoma multiforme
glioblastoma multiforme
SIRO Clinpharm and Peregrine Pharmaceuticals highlight successful collaboration
PharmaLive
Sat, 10/15/11 - 01:10 pm
Peregrine Pharmaceuticals
SIRO Clinpharm
monoclonal antibodies
glioblastoma multiforme
Cotara
ImmunoCellular Therapeutics: The Biotechnology Moneyball
Seeking Alpha
Thu, 10/6/11 - 09:34 am
ImmunoCellular
ICT-107
GBM
glioblastoma multiforme
brain cancer
ImmunoCellular Therapeutics’ ICT-107 Named One of the 100 Great Investigational Drugs for 2011
Thu, 03/31/11 - 12:53 pm
ImmunoCellular Therapeutics
ICT-107
investigational drugs
glioblastoma multiforme
cancer vaccines
Four Biotechs to Watch Early This Week
Seeking Alpha
Sun, 03/6/11 - 12:35 pm
Inhibitex
INX-189
hepatitis C
herpes zoster
shingles
S. aureus
ImmunoCellular Therapeutics
ICT107
glioblastoma multiforme
Jazz Pharmaceuticals
Repros Therapeutics
ImmunoCellular Therapeutics (IMUC): At the Forefront of Brain Tumor Treatment
Mon, 12/20/10 - 04:50 pm
ImmunoCellular Therapeutics
brain tumors
glioblastoma multiforme
Clovis Oncology
ImmunoCellular Therapeutics CEO Explains Economic Significance of New Vaccine Manufacturing Method
Wed, 10/13/10 - 11:19 pm
vaccines
ImmunoCellular Therapeutics
Dendreon
glioblastoma multiforme
ImmunoCellular Therapeutics Announces Licensing Agreement with Targepeutics for Worldwide Intellectual Property Rights to Validated Immunotherapy Target
Tue, 06/22/10 - 12:57 pm
ImmunoCellular Therapeutics
Targepeutics
glioblastoma multiforme
brain cancer
IL13Ra2
QIAGEN Unit And Pfizer Enter Into An Agreement To Develop A Companion Diagnostic For Brain Tumor Patients
Medical News Today
Sat, 02/6/10 - 12:53 pm
Qiagen
Pfizer
glioblastoma multiforme
Pages
« first
‹ previous
1
2
3